FXR agonist 3, an anti-NASH (Non-Alcoholic Steatohepatitis) agent, functions by activating FXR. It demonstrates anti-fibrogenic activity by inhibiting the expression of COL1A1, TGF-beta1, alpha-SMA, and TIMP1. Additionally, it significantly mitigates liver stea
Molecular Weight:
522.43
Formula:
C28H28BrNO4
* VAT and and shipping costs not included. Errors and price changes excepted